SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

Share Price is delayed by 15 minutes
Get Live Data
296.40    11.00 (3.85%)
Bid:
296.00
Ask:
296.40
Spread: 0.40 (0.135%)
Market Cap: £1.03b
BREE Live PriceLast checked at - London Stock Exchange

Intraday Breedon Share Chart

Total Voting Rights

31 Mar 2026 14:08

RNS Number : 8960Y
Breedon Group PLC
31 March 2026
 

 

 

 

LEI: 213800DQGNQE3X76WS92

 

31 March 2026

 

BREEDON GROUP plc

(Breedon or the Company)

 

Total Voting Rights

 

In accordance with the Disclosure Guidance and Transparency Rules (DGTR) of the Financial Conduct Authority (FCA), the Company announces the following:

 

As at the date of this announcement, the Company's issued share capital consists of 346,676,387 ordinary shares of £0.01 each in the Company (ISIN: GB00BM8NFJ84) (Ordinary Shares), of which none are held in treasury.

 

Therefore, the total number of Ordinary Shares with voting rights is 346,676,387, which may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's DGTR.

 

In accordance with the FCA's rules on Admission to Trading on a Regulated Market (PRM), the Company announces the following:

 

33,839 Ordinary Shares (Additional Ordinary Shares) have been allotted and issued between 11 February 2026 and the date of this announcement. These shares have been previously admitted to trading on the Main Market of the London Stock Exchange under an existing block admission to trading in June 2023. The total number of Ordinary Shares admitted to trading is therefore 346,676,387. The Additional Ordinary Shares are fully fungible with the existing issued Ordinary Shares.

 

- ends -

 

Enquiries:

Breedon Group plc www.breedongroup.com

James Atherton-Ham, Company Secretary +44 (0)1332 694000

 

 

MHP (Public Relations Adviser) +44 (0) 7508 012457

Reg Hoare, Rachel Farrington, Charles Hirst

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRBXGDXLGXDGLB
Date   Source Headline
1st Jun 202310:37 amRNSHolding(s) in Company
31st May 202312:35 pmRNSTotal Voting Rights
31st May 202311:30 amRNSHolding(s) in Company
24th May 202312:35 pmRNSDirector/PDMR Shareholding
23rd May 20235:31 pmRNSHolding(s) in Company
22nd May 202311:24 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
18th May 20234:52 pmRNSDirector/PDMR Shareholding
18th May 20239:00 amRNSBreedon plays key role in Peak Cluster initiative
18th May 20238:00 amRNSAcquisitions
17th May 20238:00 amRNSReadmission - Breedon Group plc
17th May 20237:00 amRNSAdmission to Main Market
12th May 20236:00 pmRNSBreedon Group
12th May 20233:50 pmRNSDirector/PDMR Shareholding
11th May 202312:56 pmRNSPublication of Prospectus
4th May 202310:06 amRNSHolding(s) in Company
28th Apr 20237:00 amRNSHolding(s) in Company
26th Apr 20234:41 pmRNSResult of Scheme Meetings & Annual General Meeting
26th Apr 20237:00 amRNSAGM Trading Update
24th Apr 20232:22 pmRNSHolding(s) in Company
13th Apr 20236:08 pmRNSHolding(s) in Company
13th Apr 202312:12 pmRNSHolding(s) in Company
12th Apr 20234:50 pmRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSPublication of Scheme Document
24th Mar 20233:49 pmRNSHolding(s) in Company
20th Mar 20239:00 amRNS2022 Annual Report and Notice of AGM
10th Mar 20235:34 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSResults of Reverse Accelerated Bookbuild
9th Mar 20234:56 pmRNSStatement re Reverse Accelerated Bookbuild
9th Mar 20231:36 pmRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSIntention to move from AIM to the Main Market
8th Mar 20237:00 amRNSFinal Results
8th Feb 20238:00 amRNSNotice of Results
6th Feb 20231:29 pmRNSDirector/PDMR Shareholding
6th Jan 202310:08 amRNSBlocklisting Update
23rd Dec 202210:00 amRNSTotal Voting Rights
19th Dec 202212:57 pmRNSHolding(s) in Company
2nd Dec 20224:01 pmRNSHolding(s) in Company
30th Nov 20229:28 amRNSTotal Voting Rights
25th Nov 20227:00 amRNSNovember trading statement
27th Oct 20224:23 pmRNSStandard form for notification of major holdings
26th Oct 20229:18 amRNSNotice of trading update
3rd Oct 20223:27 pmRNSPDMR Dealings
30th Sep 20224:20 pmRNSDirector Dealings
23rd Sep 20225:09 pmRNSStandard form for notification of major holdings
6th Sep 20225:19 pmRNSStandard form for notification of major holdings
25th Aug 20224:13 pmRNSDirector/PDMR Shareholding
27th Jul 20227:00 amRNSInterim results 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.